Equities research analysts at StockNews.com began coverage on shares of Allied Healthcare Products (NASDAQ:AHPI – Get Rating) in a research note issued on Friday. The firm set a “sell” rating on the medical equipment provider’s stock.
Allied Healthcare Products Stock Performance
Shares of AHPI opened at $1.21 on Friday. The stock has a 50-day moving average price of $1.33 and a 200-day moving average price of $1.71. The company has a market cap of $4.83 million, a PE ratio of -0.90 and a beta of -2.61. Allied Healthcare Products has a 12-month low of $1.14 and a 12-month high of $9.82. The company has a current ratio of 2.69, a quick ratio of 1.27 and a debt-to-equity ratio of 1.52.
Allied Healthcare Products (NASDAQ:AHPI – Get Rating) last announced its quarterly earnings data on Friday, October 7th. The medical equipment provider reported ($0.48) earnings per share for the quarter. Allied Healthcare Products had a negative net margin of 19.82% and a negative return on equity of 70.44%. The company had revenue of $6.02 million during the quarter.
Institutional Investors Weigh In On Allied Healthcare Products
Allied Healthcare Products Company Profile
Allied Healthcare Products, Inc manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products comprising aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, portable suction equipment, and a line of respiratory disposable products.
- Get a free copy of the StockNews.com research report on Allied Healthcare Products (AHPI)
- Institutional Support for Analog Devices Remains High
- Microsoft Shares: Is it Time to Back Up the Truck?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Three CBD Stocks to Dominate a Budding Industry
- Is the 60/40 Portfolio Mix Still in Vogue?
Receive News & Ratings for Allied Healthcare Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allied Healthcare Products and related companies with MarketBeat.com's FREE daily email newsletter.